Essential Reads: Breastfeeding and ADHD Medications
Many women taking stimulants question whether it is safe to take these medications while breastfeeding. Â
Many women taking stimulants question whether it is safe to take these medications while breastfeeding. Â
Dysphoric Milk Ejection Reflex causes brief, intense waves of dysphoria at milk letdown, often misinterpreted as postpartum depression, and can undermine breastfeeding and maternal well-being.
Weaning can be an emotionally charged transition, and for some women it may trigger depression. However, research on post-weaning depression is relatively sparse.
Treatment with zuranolone, a novel oral antidepressant for postpartum depression, raises important questions for breastfeeding individuals. While recent studies show minimal transfer into breast milk, we do not yet have enough information to recommend breastfeeding while taking zuranolone.
At this point, the medical use of cannabis is legal in 37 states and the District of Columbia (D.C.). The recreational use of cannabis has been legalized in 21 states and D.C. The downstream effect [...]
While data are limited regarding AEDs and breastfeeding, it appears that none of the AEDs are excreted at high levels into the breast milk, nor have they been associated with high rates of adverse events in the nursing infant.
A significant number of women consume cannabis while breastfeeding. What do we know about the effects of cannabis on the nursing infant?
We frequently receive questions regarding the safety of drinking alcohol while breastfeeding. While the harmful effects of alcohol use during pregnancy are well known, we have much less information regarding the consequences of alcohol [...]
In an effort to decrease the spread of COVID-19, public health officials have recommended that we minimize close physical contact with others and furthermore require those with either suspected or confirmed COVID-19 infection to [...]
While we have adequate data to support the use of SSRI antidepressants during pregnancy, there is less data regarding other classes of antidepressants. A new case series documents the outcomes of infants exposed to mirtazapine (Remeron).